The DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.
Guidance Document on Good In Vitro Method Practices (GIVIMP)
Abstract
The Organisation for Economic Co-operation and Development (OECD) is an intergovernmental organisation in which representatives of 36 industrialised countries in North and South America, Europe and the Asia and Pacific region, as well as the European Commission, meet to co-ordinate and harmonise policies, discuss issues of mutual concern, and work together to respond to international problems.Most of the OECD's work is carried out by more than 200 specialised committees and working groups composed of member country delegates.Observers from several countries with special status at the OECD, and from interested international organisations, attend many of the OECD's workshops and other meetings.Committees and working groups are served by the OECD Secretariat, located in Paris, France, which is organised into directorates and divisions.The Environment, Health and Safety Division publishes free-of-charge documents in twelve different series: Testing and Assessment; Good Laboratory Practice and Compliance Monitoring; Pesticides;
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The current testing paradigm for DNT mainly relies on results on results from in vivo guideline studies (OECD TG 426 (OECD 2007), OECD TG 443 with DNT cohort (OECD 2018a)).”
From Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology (2025) · cites this paper as OECD 2018a
In the citing paper
“The document provides guidance for development and implementation of cellular methods generating data for regulatory safety assessment.”
From Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology (2025) · cites this paper as OECD 2018b
In the citing paper
“Even if imaging technologies are not specifically covered, other important aspects related to in vitro methods (e.g., facilities, test systems, reference/control items, SOPs) are explained.”
From Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology (2025) · cites this paper as OECD 2018b
In the citing paper
“A significant step forward was the publication of the Guidance Document on Good In Vitro Method Practices (GIVIMP) by OECD in 2018 (OECD 2018b).”
From Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology (2025) · cites this paper as OECD 2018b
In the citing paper
“In addition, serum is a complex mixture of different factors, which introduces undefined constituents within the culture medium. Many of these components have not yet been identified, and in several cases, their effects on cell/tissue cultures are still unknown [18, 20].”
From A worldwide survey on the use of animal‐derived materials and reagents in scientific experimentation (2022) · cites this paper as [18]
In the citing paper
“Notably, all animal‐derived materials and reagents are obtained from different animal groups and result in batch‐to‐batch variation, which may lead to reliability and integrity concerns for generated in vitro data [18, 19].”
From A worldwide survey on the use of animal‐derived materials and reagents in scientific experimentation (2022) · cites this paper as [18]
In the citing paper
“Regulatory frameworks already provide clear guidance in his direction: the OECD Good Ín Vitro Method Practices (GIVIMP) guidelines recommend minimizing or eliminating undefined components such as FBS (OECD, 2018), while the Centre for the Validation of Alternative Methods Scientific Advisory Committee (ESAC) recommends avoiding FBS use unless scientifically justified (van der Valk et al., 2018).”
From Challenges and solutions in transitioning to animal-free standards: a comprehensive analysis of components in human cell-based developmental neurotoxicity assays (2026) · cites this paper as OECD, 2018
Citations
Cites
Motulsky, H. J., & Christopoulos, A. (2004) · Cited by 1,972
Motulsky, H. J., & Brown, R. E. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-123 · Cited by 1,616
Toxicity testing in the 21st century: A vision and a strategy
Gibb, S. (2007) · Reproductive Toxicology · doi:10.1016/j.reprotox.2007.10.013 · Cited by 1,256
Spheroid culture as a tool for creating 3D complex tissues
Fennema, E., Rivron, N., Rouwkema, J., van Blitterswijk, C., & de Boer, J. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.12.003 · Cited by 1,054
Viswanathan, C. T., Bansal, S. K., Booth, B. P., DeStefano, A. J., Rose, M. J., Sailstad, J. M., Shah, V. P., Skelly, J. P., Swann, P. G., & WEINER, R. S. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9291-7 · Cited by 826
A practical approach to RT-qPCR—Publishing data that conform to the MIQE guidelines
Taylor, S., Wakem, M., Dijkman, G., Alsarraj, M., & Nguyen, M. (2010) · Methods · doi:10.1016/j.ymeth.2010.01.005 · Cited by 776
van der Valk, J., Brunner, D., Smet, K. D., Svenningsen, Å. F., Honegger, P., Knudsen, L. E., Lindl, T., Noraberg, J., Price, A., Scarino, M. L., et al. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.03.016 · Cited by 657
Co-culture systems and technologies: taking synthetic biology to the next level
Goers, L., Freemont, P. S., & Polizzi, K. M. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0065 · Cited by 623
Judson, R., Houck, K. A., Kavlock, R. J., Knudsen, T. B., Martin, M. T., Mortensen, H. M., Reif, D. M., Rotroff, D. M., Shah, I., Richard, A. M., et al. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0901392 · Cited by 610
Validation of Laboratory-Developed Molecular Assays for Infectious Diseases
Burd, E. M. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00074-09 · Cited by 550 · cited 1×
“(Burd, 2010[27]; EMA, 2011[5]; FDA, 2001[6]; Viswanathan et al., 2007[28]).”
Cited by
Sorted by citations
Olker, J. H., Elonen, C. M., Pilli, A., Anderson, A., Kinziger, B., Erickson, S., Skopinski, M., Pomplun, A., LaLone, C. A., Russom, C. L., et al. (2022) · Environmental Toxicology and Chemistry · doi:10.1002/etc.5324 · Cited by 317
Marx, U. (2020) · ALTEX · doi:10.14573/altex.2001241 · Cited by 291
Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades
Göller, A. H., Kuhnke, L., Montanari, F., Bonin, A., Schneckener, S., ter Laak, A., Wichard, J., Lobell, M., & Hillisch, A. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.07.001 · Cited by 215
The alamar blue assay in the context of safety testing of nanomaterials
Longhin, E., Yamani, N. E., Rundén‐Pran, E., & Dušinská, M. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.981701 · Cited by 174
A Beginner’s Guide to Cell Culture: Practical Advice for Preventing Needless Problems
Weiskirchen, S., Schröder, S. K., Buhl, E. M., & Weiskirchen, R. (2023) · Cells · doi:10.3390/cells12050682 · Cited by 148
Test No. 442E: In Vitro Skin Sensitisation
OECD (2016) · OECD guidelines for the testing of chemicals. Section 4: Health effects · doi:10.1787/9789264264359-en · Cited by 135
Self-citationHampton, L. M. T., Bouwmeester, H., Brander, S. M., Coffin, S., Cole, M., Hermabessière, L., Mehinto, A. C., Miller, E. L., Rochman, C. M., & Weisberg, S. B. (2022) · Microplastics and Nanoplastics · doi:10.1186/s43591-022-00038-y · Cited by 128
Development of a Roadmap for Action on New Approach Methodologies in Risk Assessment
Escher, S. E., Partosch, F., Konzok, S., Jennings, P., Luijten, M., Kienhuis, A. S., de Leeuw, V. C., Reuss, R., Lindemann, K.-M., & Bennekou, S. H. (2022) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2022.en-7341 · Cited by 108
Guidance document on Good cell and tissue culture practice 2.0 (GCCP 2.0)
Pamies, D. (2021) · ALTEX · doi:10.14573/altex.2111011 · Cited by 100
Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges
Wang, D., Villenave, R., Stokar‐Regenscheit, N., & Clevers, H. C. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01317-y · Cited by 111
Safer chemicals using less animals: kick-off of the European ONTOX project
Vinken, M., Benfenati, E., Busquet, F., Castell, J. V., Clevert, D.-A., de Kok, T. M. C. M., Dirven, H. A. A. M., Fritsche, E., Geris, L., Gozalbes, R., et al. (2021) · Toxicology · doi:10.1016/j.tox.2021.152846 · Cited by 80
Gouin, T., Ellis‐Hutchings, R. G., Hampton, L. M. T., Lemieux, C. L., & Wright, S. (2022) · Microplastics and Nanoplastics · doi:10.1186/s43591-021-00023-x · Cited by 83
Cell line authentication: a necessity for reproducible biomedical research
Souren, N. Y., Fusenig, N. E., Heck, S., Dirks, W. G., Capes‐Davis, A., Bianchini, F., & Plass, C. (2022) · The EMBO Journal · doi:10.15252/embj.2022111307 · Cited by 73
Barošová, H., Meldrum, K., Karakoçak, B. B., Balog, S., Doak, S. H., Petri‐Fink, A., Clift, M. J. D., & Rothen‐Rutishauser, B. (2021) · Toxicology in Vitro · doi:10.1016/j.tiv.2021.105178 · Cited by 71
Advanced in vitro lung-on-chip platforms for inhalation assays: From prospect to pipeline
Artzy‐Schnirman, A., Hobi, N., Schneider‐Daum, N., Guenat, O. T., Lehr, C., & Sznitman, J. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.09.006 · Cited by 73
Optimizing drug discovery by Investigative Toxicology: Current and future trends
Beilmann, M. (2018) · ALTEX · doi:10.14573/altex.1808181 · Cited by 78
Bas, A., Burns, N., Gulotta, A., Junker, J., Drasler, B., Lehner, R., Aicher, L., Constant, S., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2021) · Small · doi:10.1002/smll.202006027 · Cited by 60
Pluripotent Stem Cell Heterogeneity
Hayashi, Y., Ohnuma, K., & Furue, M. K. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-11096-3_6 · Cited by 60
OECD approaches and considerations for regulatory evaluation of endocrine disruptors
Browne, P., van der Wal, L., & Gourmelon, A. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110675 · Cited by 58
Nigussie, D., Makonnen, E., Tufa, T. B., Brewster, M., Legesse, B. A., Fekadu, A., & Davey, G. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114179 · Cited by 60
Magurany, K. A., Chang, X., Clewell, R. A., Coecke, S., Haugabrooks, E. M., & Marty, S. (2023) · Toxicological Sciences · doi:10.1093/toxsci/kfad012 · Cited by 66
Han, P., Li, X., Yang, J., Zhang, Y., & Chen, J. (2024) · Environment & Health · doi:10.1021/envhealth.4c00043 · Cited by 52
Wang, R., Mohammadi, M. Y., Mahboubi, A., & Taherzadeh, M. J. (2021) · Bioengineered · doi:10.1080/21655979.2021.1940769 · Cited by 56
Ouédraogo, G., Alépée, N., Tan, B., & Roper, C. S. (2025) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2025.105904 · Cited by 59
Huck, B. C., Murgia, X., Frisch, S., Hittinger, M., Hidalgo, A., Loretz, B., & Lehr, C. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114141 · Cited by 50
Krebs, A., van Vugt‐Lussenburg, B. M. A., Waldmann, T., Albrecht, W., Boei, J. J. W. A., ter Braak, B., Brajnik, M., Braunbeck, T. A., Brecklinghaus, T., Busquet, F., et al. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02802-6 · Cited by 49
Scientific Validation of Human Neurosphere Assays for Developmental Neurotoxicity Evaluation
Koch, K., Bartmann, K., Hartmann, J., Kapr, J., Klose, J., Kuchovská, E., Pahl, M., Schlüppmann, K., Zühr, E., & Fritsche, E. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.816370 · Cited by 48
OECD (2016) · OECD guidelines for the testing of chemicals. Section 4: Health effects · doi:10.1787/9789264264366-en · Cited by 51
Self-citationThe future of cultured meat between sustainability expectations and socio-economic challenges
Mancini, M. C., & Antonioli, F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91001-9.00024-4 · Cited by 52
Crofton, K. M., & Mundy, W. R. (2021) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2021.en-6924 · Cited by 50
Beyond AOPs: A Mechanistic Evaluation of NAMs in DART Testing
Rajagopal, R., Baltazar, M. T., Carmichael, P. L., Dent, M. P., Head, J., Li, H., Müller, I. I., Reynolds, J., Sadh, K., Simpson, W., et al. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.838466 · Cited by 45
Usmani, S. M., Bremer‐Hoffmann, S., Cheyns, K., Cubadda, F., Dumit, V. I., Escher, S. E., Fessard, V., Gutleb, A. C., Léger, T., Liu, Y., et al. (2024) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2024.en-8826 · Cited by 47
Collet, B., Simon, E., van der Linden, S., el Abdellaoui, N., Naderman, M., Man, H.-Y., Middelhof, I., van der Burg, B., Besselink, H. T., & Brouwer, A. (2019) · Reproductive Toxicology · doi:10.1016/j.reprotox.2019.05.011 · Cited by 43
Nauwelaerts, N., Deferm, N., Smits, A., Bernardini, C., Lammens, B., Gandia, P., Panchaud, A., Nordeng, H., Bacci, M. L., Forni, M., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111038 · Cited by 46
Mhaouty‐Kodja, S., Zalko, D., Tait, S., Testai, E., Viguié, C., Corsini, E., Grova, N., Buratti, F. M., Cabaton, N. J., Coppola, L., et al. (2024) · Critical Reviews in Toxicology · doi:10.1080/10408444.2024.2388712 · Cited by 41
Maximizing the relevance and reproducibility of A549 cell culture using FBS-free media
Chary, A., Groff, K., Stucki, A., Contal, S., Stoffels, C., Cambier, S., Sharma, M., Gutleb, A. C., & Clippinger, A. J. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105423 · Cited by 38
An inter-laboratory effort to harmonize the cell-delivered in vitro dose of aerosolized materials
Bannuscher, A., Schmid, O., Drašler, B., Rohrbasser, A., Braakhuis, H., Meldrum, K., Zwart, E., Gremmer, E. R., Birk, B., Rissel, M., et al. (2022) · NanoImpact · doi:10.1016/j.impact.2022.100439 · Cited by 38
The Material World of 3D‐Bioprinted and Microfluidic‐Chip Models of Human Liver Fibrosis
Carvalho, A. M., Bansal, R., Barrias, C. C., & Sarmento, B. F. C. C. (2023) · Advanced Materials · doi:10.1002/adma.202307673 · Cited by 36
Pharmacokinetics‐On‐a‐Chip: In Vitro Microphysiological Models for Emulating of Drugs ADME
Ramadan, Q., Fardous, R. S., Hazaymeh, R., Alshmmari, S. K., & Zourob, M. M. (2021) · Advanced Biology · doi:10.1002/adbi.202100775 · Cited by 37
Paini, A., Tan, Y., Sachana, M., & Worth, A. P. (2021) · Computational Toxicology · doi:10.1016/j.comtox.2021.100163 · Cited by 33
A worldwide survey on the use of animal‐derived materials and reagents in scientific experimentation
Cassotta, M., Bartnicka, J. J., Pistollato, F., Parvatam, S., Weber, T., D'Alessandro, V., Bastos, L. F., & Coecke, S. (2022) · Engineering in Life Sciences · doi:10.1002/elsc.202100167 · Cited by 33
Birch, H., Kramer, N. I., & Mayer, P. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00133 · Cited by 32
Lungu-Mitea, S., Vogs, C., Carlsson, G., Montag, M., Frieberg, K., Oskarsson, A., & Lundqvist, J. (2020) · Environmental Science & Technology · doi:10.1021/acs.est.0c04872 · Cited by 30
Evaluating confidence in toxicity assessments based on experimental data and in silico predictions
Johnson, C., Anger, L. T., Benigni, R., Bower, D., Bringezu, F., Crofton, K. M., Cronin, M., Cross, K. P., Dettwiler, M., Frericks, M., et al. (2021) · Computational Toxicology · doi:10.1016/j.comtox.2021.100204 · Cited by 29
Bridgeman, L., Pamies, D., & Frangiamone, M. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.139562 · Cited by 29
Bearth, A., Roth, N., Jansen, T., Holden, L., Čavoški, A., Consiglio, E. D., Hauzenberger, I., Lee, R., Mombelli, E., Tcheremenskaia, O., et al. (2025) · Environment International · doi:10.1016/j.envint.2025.109279 · Cited by 30
Towards the development of standardised sea turtle primary cell cultures for toxicity testing
Finlayson, K. A., Leusch, F. D. L., Limpus, C. J., & van de Merwe, J. P. (2019) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2019.01.117 · Cited by 25
Niethammer, M., Burgdorf, T., Wistorf, E., Schönfelder, G., & Kleinsorge, M. (2022) · Development · doi:10.1242/dev.200933 · Cited by 26
The value of organs-on-chip for regulatory safety assessment
Heringa, M. B. (2019) · ALTEX · doi:10.14573/altex.1910111 · Cited by 27
Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs
Matera, M. G., Calzetta, L., Ora, J., Rogliani, P., & Cazzola, M. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1873271 · Cited by 23
Wiklund, L., & Beronius, A. (2022) · Toxicology · doi:10.1016/j.tox.2022.153255 · Cited by 24
Jeliazkova, N., Longhin, E., Yamani, N. E., Rundén‐Pran, E., Moschini, E., Serchi, T., Vrček, I. V., Burgum, M. J., Doak, S. H., Cimpan, M. R., et al. (2024) · Nature Protocols · doi:10.1038/s41596-024-00993-1 · Cited by 23
Alves, A. D. O., Weis, G. C. C., Unfer, T. C., Assmann, C. E., Barbisan, F., Azzolin, V. F., Chitolina, B., Duarte, T., Filho, E. E. R., Duarte, M. M. M. F., et al. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110809 · Cited by 21
Sharma, M., Huber, E. A., Arnesdotter, E., Behrsing, H. P., Bettmann, A., Brandwein, D., Constant, S., Date, R., Deshpande, A., Fabian, E. J., et al. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03879-z · Cited by 20
Bell, L., Simonneau, C., Zanini, C., Kassianidou, E., Zundel, C., Neff, R., Steinhuber, B., Tecilla, M., Odermatt, A., Villaseñor, R., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40813 · Cited by 23
OECD (2011) · OECD studies on water · doi:10.1787/22245081 · Cited by 20
Self-citationAdaptation of Mammalian Cells to Chemically Defined Media
Marigliani, B., Balottin, L. B. L., & Augusto, E. D. F. P. (2019) · Current Protocols in Toxicology · doi:10.1002/cptx.88 · Cited by 19
Academic application of Good Cell Culture Practice for induced pluripotent stem cells
Tigges, J. (2021) · ALTEX · doi:10.14573/altex.2101221 · Cited by 21
Naik, N. N., Vadloori, B., Poosala, S., Srivastava, P., Coecke, S., Smith, A. J., Akhtar, A. Z., Roper, C. S., Radhakrishnan, S., Bhyravbhatla, B., et al. (2023) · Alternatives to Laboratory Animals · doi:10.1177/02611929231180428 · Cited by 16
A modular strategy for the testing and assessment of non-genotoxic carcinogens
Louekari, K., & Jacobs, M. N. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03753-y · Cited by 17
Haase, A., Barroso, J., Bogni, A., Bremer‐Hoffmann, S., Fessard, V., Gutleb, A. C., Mast, J., McVey, E. A., Mertens, B., Oomen, A. G., et al. (2024) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2024.en-9008 · Cited by 19
Impact of Nanocomposite Combustion Aerosols on A549 Cells and a 3D Airway Model
Hufnagel, M., May, N., Wall, J., Wingert, N., Garcia‐Käufer, M., Arif, A., Hübner, C., Berger, M., Mülhopt, S., Baumann, W., et al. (2021) · Nanomaterials · doi:10.3390/nano11071685 · Cited by 17
How a GIVIMP certification program can increase confidence in in vitro methods
Ulrey, A. (2021) · ALTEX · doi:10.14573/altex.2102261 · Cited by 17
Liu, R., Novák, J., & Hilscherová, K. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03766-7 · Cited by 16
Animal-free safety assessment of chemicals: an innovation system perspective
Hoogstraaten, M. J., Vriend, J., de Leeuw, V. C., Negro, S. O., Moors, E. H. M., Kienhuis, A. S., & Hoekman, J. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03878-0 · Cited by 18
Assis, M., de Souza, A., Sousa, K. D. S. J., Nina, D. G. N., Bonifácio, M., Granito, R. N., & Rennó, A. C. M. (2025) · Journal of Applied Toxicology · doi:10.1002/jat.4836 · Cited by 15
Komarnisky, R.-M., Wootten, S., Friedman, N., & Nikkhah, M. (2025) · Lab on a Chip · doi:10.1039/d5lc00426h · Cited by 16
Maldaner, D. R., Pellenz, N. L. K., Barbisan, F., Azzolin, V. F., Mastella, M. H., Teixeira, C. F., Duarte, T., Maia‐Ribeiro, E. A., da Cruz, I. B. M., & Duarte, M. M. M. F. (2019) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.13055 · Cited by 15
Reporting In Vitro Experiments Responsibly – the RIVER RecommendationsPreprint
The RIVER working group (2023) · MetArXiv (OSF Preprints) · doi:10.31222/osf.io/x6aut · Cited by 18
Identifying assessment criteria for in vitro studies: a method and item bank
Whaley, P., Blain, R. B., Draper, D. T., Rooney, A. A., Walker, V. R., Wattam, S., Wright, R., & Hooijmans, C. R. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae083 · Cited by 13
Nian, M., Chen, X., & Fang, M. (2025) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.4c00555 · Cited by 13
Development of a reference and proficiency chemical list for human steatosis endpoints in vitro
Kubíčková, B., & Jacobs, M. N. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1126880 · Cited by 13
Gabbert, S., Mathea, M., Kolle, S. N., & Landsiedel, R. (2022) · Risk Analysis · doi:10.1111/risa.13648 · Cited by 17
Training the next generation of researchers in the organ-on-chip field
Moruzzi, A., Shroff, T., Keller, S., Loskill, P., & Cipriano, M. (2023) · Education Sciences · doi:10.3390/educsci13020144 · Cited by 12
Regulatory use and acceptance of alternative methods for chemical hazard identification
Browne, P., Delrue, N., & Gourmelon, A. (2019) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2019.02.003 · Cited by 12
Llewellyn, S. V., Kermanizadeh, A., Ude, V. C., Jacobsen, N. R., Conway, G. E., Shah, U.-K., Niemeijer, M., Moné, M. J., van de Water, B., Roy, S. K., et al. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105473 · Cited by 12
Chacón, M., Vázquez, N., Persinal-Medina, M., Alonso‐Alonso, S., Pevida, M., Llames, S. G., Baamonde, B. M., Quirós, L. M., Merayo-Llovés, J., & Meana, Á. (2020) · Toxicology in Vitro · doi:10.1016/j.tiv.2020.104779 · Cited by 11
Özçağlı, E., Kubíčková, B., & Jacobs, M. N. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1401120 · Cited by 10
Journeying Through Journals: The Publishing Process and How to Maximise Research Impact
Madden, J. C., Kanďárová, H., Neuhaus, W., Osborne, N., Paini, A., Seabra, R., & Trigwell, S. M. (2024) · Alternatives to Laboratory Animals · doi:10.1177/02611929241286624 · Cited by 11
Malinowska, J. M., & Whelan, M. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04119-8 · Cited by 12
The Accomplishments of KoCVAM in the Development and Implementation of Alternative Methods in Korea
Kang, N.-H., & Oh, J.-H. (2024) · Alternatives to Laboratory Animals · doi:10.1177/02611929241244520 · Cited by 10
Panwar, S., Kumari, A., Kumar, H., Tiwari, A. K., Tripathi, P., & Asthana, S. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1943526 · Cited by 10
Deschamps, C. (2022) · ALTEX · doi:10.14573/altex.2109011 · Cited by 10
(PPR), E. P. O. P. P. P. A. T. R., Čoja, T., Adriaanse, P., Choi, J., Finizio, A., Giraudo, M., Kühl, T., McVey, E., Metruccio, F., Paparella, M., et al. (2025) · EFSA Journal · doi:10.2903/j.efsa.2025.9814 · Cited by 10
Human-Derived In Vitro Models Used for Skin Toxicity Testing Under REACh
Kolle, S. N., & Landsiedel, R. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_368 · Cited by 9
Leite, S. B., Brooke, M., Carusi, A., Collings, A., Deceuninck, P., Dechamp, J.-F., Dekker, B. A., Ranieri, E. D., Ganley, E., Gastaldello, A., et al. (2023) · doi:10.31219/osf.io/x85gh · Cited by 9
Holzer, A.-K. (2023) · ALTEX · doi:10.14573/altex.2310021 · Cited by 8
ToxProfiler: A novel human-based reporter assay for in vitro chemical safety assessment
ter Braak, B., Wolters, L., Elbertse, K., Østerlund, T., Hendriks, G., & Jamalpoor, A. (2024) · Toxicology · doi:10.1016/j.tox.2024.153970 · Cited by 9
A novel TEM grid sampler for airborne particles to measure the cell culture surface dose
Mülhopt, S., Schlager, C., Berger, M., Murugadoss, S., Hoet, P., Krebs, T., Paur, H. ‐., & Stapf, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-65427-w · Cited by 8
Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology
Piergiovanni, M., Mennecozzi, M., Barale-Thomas, E., Danovi, D., Dunst, S., Egan, D., Fassi, A., Hartley, M., Kainz, P., Koch, K., et al. (2025) · Archives of Toxicology · doi:10.1007/s00204-024-03922-z · Cited by 9
Challenges of in vitro modelling of liver fibrosis
Ros-Tárraga, P., Villanueva-Bádenas, E., Sanchez-Gonzalez, E., Ferrer, G. G., Donato, M. T., & Tolosa, L. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1567916 · Cited by 11
Rogiers, V., Benfenati, E., Bernauer, U., Bodin, L., Browne, P., Cabaton, N. J., Chaudhry, Q., Coenraads, P. J., Corsini, E., Dent, M. P., et al. (2026) · Archives of Toxicology · doi:10.1007/s00204-025-04275-x · Cited by 9
Kim, S., Lee, T., Ryu, M., Park, Y., & Moon, S. (2026) · Journal of Applied Toxicology · doi:10.1002/jat.70059 · Cited by 8
Lefevre, M. C., Bernardeschi, M., Battaglini, M., & Ciofani, G. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202505218 · Cited by 6
Bonaccorsi, S. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837673476-00461 · Cited by 7
Cöllen, E., Tanaskov, Y., Holzer, A., Dipalo, M., Schäfer, J., Kraushaar, U., & Leist, M. (2024) · ALTEX · doi:10.14573/altex.2401041 · Cited by 6
How Qualification of 3D Disease Models Cuts the Gordian Knot in Preclinical Drug Development
Schäfer‐Korting, M., & Zoschke, C. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_374 · Cited by 6
PETRICCS Guideline Protocol: A Call to Improve Reporting Standards in Cell Culture Research
Monteiro, M. M., dos Santos, J. A., Barbosa, V. P., Canto, G. D. L., SQUARIZE, C. H., Coletta, R. D., & Guerra, E. N. S. (2025) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.13605 · Cited by 5
LaFollette, M. R., Baran, S. W., Curley, J. L., Dickinson, A. M., Frazier, T. P., Hobi, N., Huang, M.-I., Hutter, V., Maisonneuve, B. G. C., Marsh, G., et al. (2025) · Alternatives to Laboratory Animals · doi:10.1177/02611929241310566 · Cited by 5
Nigussie, D., Legesse, B. A., Davey, G., Fekadu, A., & Makonnen, E. (2020) · BMJ Open Science · doi:10.1136/bmjos-2020-100064 · Cited by 5
Metadata
- Authors
- OECD
- Corresponding author
- OECD
- Venue
- OECD Series on Testing and Assessment
- Publisher
- OECD Publishing
- Published
- 2018-12-10
- ISSN
- 2077-7876 (ISSN-L)
- OpenAlex
- W4251582862
- Cited by
- 161
- References
- 199
- Citations by year
- 2026: 29 · 2025: 29 · 2024: 24 · 2023: 12 · 2022: 18 · 2021: 20 · 2020: 11 · 2019: 12 · 2018: 1
- FWCI
- 10.38
- Type
- book
- Language
- en
- Open access
- closed
- Locations
- OECD series on testing and assessment (publishedVersion)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Agricultural and Biological Sciences › Food Science › Agricultural safety and regulations
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Keywords
- in vitro toxicity testing, test reproducibility, test reliability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
